Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Management of hereditary ovarian cancer].

Orvosi hetilap - 2 Oct 2011

Joó József Gábor, Ládi Szabolcs, Nagy B Zsolt, Langmár Zoltán

Abstract excerpt

Mutations in BRCA1 and BRCA2 genes account for the majority of hereditary breast and ovarian cancers. Approximately 10% of cases of ovarian cancer are due to germline mutations in BRCA1 and BRCA2. Ovarian cancer associated with BRCA1 and BRCA2 mutations has a distinct histological phenotype. This type of cancer is predominantly of serous or endometrioid histology and is high grade. Patients with BRCA1 or BRCA2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Distribution
Share to CA-125 Antigen
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fallopian Tubes

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Ovariectomy

Share to Precision Medicine

Source

Identifiers

PMID: 21945869
DOI: 10.1556/OH.2011.29218

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Management of hereditary ovarian cancer].PMID 21945869Read ↗

[Hereditary ovarian carcinomas: clinico-biological features and treatment].Semantic proximity Read ↗

[Hereditary breast and ovarian cancer syndrome: Diagnosis and therapeutic implications].Semantic proximity Read ↗

[BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer].Semantic proximity Read ↗

Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.Semantic proximity Read ↗

Hereditary ovarian cancer: recent molecular insights and their impact on screening strategies.Semantic proximity Read ↗

Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal.Semantic proximity Read ↗

Wise Management of Ovarian Cancer: On the Cutting EdgeSemantic proximity Read ↗

Managing hereditary breast cancer risk in women with and without ovarian cancer.Semantic proximity Read ↗

Managing hereditary ovarian cancer.Semantic proximity Read ↗

Ovarian cancer: identifying and managing familial and genetic risk-summary of new NICE guidance.Semantic proximity Read ↗

[Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers].Semantic proximity Read ↗

[Hereditary ovarian cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.